De novo CLTC variants are associated with a variable phenotype from mild to severe intellectual disability, microcephaly, hypoplasia of the corpus callosum, and epilepsy.
CLTC
intellectual disability
neurodevelopmental disorder
Journal
Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
24
05
2019
accepted:
06
11
2019
revised:
14
10
2019
pubmed:
30
11
2019
medline:
28
4
2021
entrez:
29
11
2019
Statut:
ppublish
Résumé
To delineate the genotype-phenotype correlation in individuals with likely pathogenic variants in the CLTC gene. We describe 13 individuals with de novo CLTC variants. Causality of variants was determined by using the tolerance landscape of CLTC and computer-assisted molecular modeling where applicable. Phenotypic abnormalities observed in the individuals identified with missense and in-frame variants were compared with those with nonsense or frameshift variants in CLTC. All de novo variants were judged to be causal. Combining our data with that of 14 previously reported affected individuals (n = 27), all had intellectual disability (ID), ranging from mild to moderate/severe, with or without additional neurologic, behavioral, craniofacial, ophthalmologic, and gastrointestinal features. Microcephaly, hypoplasia of the corpus callosum, and epilepsy were more frequently observed in individuals with missense and in-frame variants than in those with nonsense and frameshift variants. However, this difference was not significant. The wide phenotypic variability associated with likely pathogenic CLTC variants seems to be associated with allelic heterogeneity. The detailed clinical characterization of a larger cohort of individuals with pathogenic CLTC variants is warranted to support the hypothesis that missense and in-frame variants exert a dominant-negative effect, whereas the nonsense and frameshift variants would result in haploinsufficiency.
Identifiants
pubmed: 31776469
doi: 10.1038/s41436-019-0703-y
pii: S1098-3600(21)01146-1
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
797-802Références
Hamdan FF, Myers CT, Cossette P, et al. High rate of recurrent de novo mutations in developmental and epileptic encephalopathies. Am J Hum Genet. 2017;101:664–685.
doi: 10.1016/j.ajhg.2017.09.008
DeMari J, Mroske C, Tang S, Nimeh J, Miller R, Lebel RR. CLTC as a clinically novel gene associated with multiple malformations and developmental delay. Am J Med Genet A. 2016;170A:958–966.
doi: 10.1002/ajmg.a.37506
Manti F, Nardecchia F, Barresi S, et al. Neurotransmitter trafficking defect in a patient with clathrin (CLTC) variation presenting with intellectual disability and early-onset parkinsonism. Parkinsonism Relat Disord. 2019;61:207–210.
doi: 10.1016/j.parkreldis.2018.10.012
Lelieveld SH, Reijnders MR, Pfundt R, et al. Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability. Nat Neurosci. 2016;19:1194–1196.
doi: 10.1038/nn.4352
Dodge GR, Kovalszky I, McBride OW, et al. Human clathrin heavy chain (CLTC): partial molecular cloning, expression, and mapping of the gene to human chromosome 17q11-qter. Genomics. 1991;11:174–178.
doi: 10.1016/0888-7543(91)90115-U
Kaksonen M, Roux A. Mechanisms of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol. 2018;19:313–326.
doi: 10.1038/nrm.2017.132
Royle SJ, Bright NA, Lagnado L. Clathrin is required for the function of the mitotic spindle. Nature. 2005;434:1152–1157.
doi: 10.1038/nature03502
Kasprowicz J, Kuenen S, Miskiewicz K, Habets RL, Smitz L, Verstreken P. Inactivation of clathrin heavy chain inhibits synaptic recycling but allows bulk membrane uptake. J Cell Biol. 2008;182:1007–1016.
doi: 10.1083/jcb.200804162
Sobreira N, Schiettecatte F, Valle D, Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum Mutat. 2015;36:928–930.
doi: 10.1002/humu.22844
Neveling K, Feenstra I, Gilissen C, et al. A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases. Hum Mutat. 2013;34:1721–1726.
doi: 10.1002/humu.22450
Wiel L, Baakman C, Gilissen D, Veltman JA, Vriend G, Gilissen C. MetaDome: pathogenicity analysis of genetic variants through aggregation of homologous human protein domains. Hum Mutat. 2019;40:1030–1038.
doi: 10.1002/humu.23892
Lek M, Karczewski KJ, Minikel EV, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–291.
doi: 10.1038/nature19057
Fotin A, Cheng Y, Sliz P, et al. Molecular model for a complete clathrin lattice from electron cryomicroscopy. Nature. 2004;432:573–579.
doi: 10.1038/nature03079
Krieger E, Koraimann G, Vriend G. Increasing the precision of comparative models with YASARA NOVA—a self-parameterizing force field. Proteins. 2002;47:393–402.
doi: 10.1002/prot.10104
Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310–315.
doi: 10.1038/ng.2892
Wilbur JD, Hwang PK, Ybe JA, et al. Conformation switching of clathrin light chain regulates clathrin lattice assembly. Dev Cell. 2010;18:841–848.
doi: 10.1016/j.devcel.2010.04.007
Bosch DG, Boonstra FN, de Leeuw N, et al. Novel genetic causes for cerebral visual impairment. Eur J Hum Genet. 2016;24:660–665.
doi: 10.1038/ejhg.2015.186